Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Carpobrotus edulis* methanolic extract is a botanical extract derived from the succulent plant *Carpobrotus edulis*, commonly known as the sour fig. Research conducted at the University of Johannesburg has investigated its potential as an anticancer agent, specifically targeting pancreatic cancer. The extract and its isolated compounds, such as 7,9-Ditert-butyl-oxaspiro [4.5] deca-6,9-diene-2,8-dione and 1-octadecanol, appear to induce apoptosis in MIA PaCa2 pancreatic cancer cells without affecting non-cancerous MRC-5 cells. Mechanistically, the extract activates the extrinsic TNF-mediated apoptosis pathway, increasing TNF expression and caspase 3/7 activity, while inhibiting cell growth through the downregulation of STAT3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carpobrotus edulis methanolic extract.